Status:
UNKNOWN
Postoperative Cardiovascular Index Change of Primary Aldosteronism
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Aldosteronism
Eligibility:
All Genders
18-80 years
Brief Summary
Primary aldosteronism (PA), characterized by an inappropriate production of aldosterone, is far more common than is usually perceived. The overall prevalence of PA is 11.2% of the newly diagnosed hype...
Detailed Description
Aldosterone has rapid nongenomic effects in the human vasculature. Aldosterone has been claimed to lead to endothelial dysfunction, a condition related to development of cardiovascular disorders and t...
Eligibility Criteria
Inclusion
- aldosteronism with hyperaldosterone
- older than 18 year of age
- completed the informed consent
Exclusion
- pregnancy
- bed-ridden
- could not do MRI
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00746070
Start Date
January 1 2007
End Date
January 1 2013
Last Update
May 4 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.